{"id":"W2106286200","doi":"10.1200/jco.2009.26.3756","title":"American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer","year":2010,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":798,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American Society of Clinical Oncology","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Adverse effect; Internal medicine; Adjuvant therapy; Guideline; Cancer; Hormone therapy; Clinical trial; Gynecology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01156823,0.0008797977,0.01100291,0.0001019422,0.0001151454,0.00001615643,0.0009402934,0.002148467,0.00005815637],"category_scores_gemma":[0.004818075,0.0005455349,0.003823616,0.0002738191,0.002265074,0.00002604142,0.0003126845,0.003701881,0.00001055606],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003957243,"about_ca_system_score_gemma":0.01192211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008498683,"about_ca_topic_score_gemma":0.00008910544,"domain_scores_codex":[0.9835103,0.003279822,0.01064249,0.001175437,0.0005986994,0.0007932499],"domain_scores_gemma":[0.965619,0.009288607,0.02044918,0.0007925035,0.003103553,0.0007471363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03608499,0.005459837,0.0005167733,0.0001684813,0.01002266,0.00005724662,0.00002602469,0.000002312101,0.000009333709,0.00001134011,0.07530333,0.8723376],"study_design_scores_gemma":[0.01238776,0.06049409,0.003781042,0.0005996416,0.002495129,0.0005741824,0.0001640802,0.000001627733,0.000006102505,0.00001391838,0.9190003,0.0004821369],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004361953,0.9650766,0.0003288338,0.02097882,0.005001836,0.001948397,0.001564924,0.00001792985,0.0007207576],"genre_scores_gemma":[0.0003847126,0.9478655,0.03050111,0.009259067,0.01130147,0.0002588328,0.0001619101,0.0001376951,0.0001296388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8718555,"threshold_uncertainty_score":0.9996996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1033942419119506,"score_gpt":0.5353548132279201,"score_spread":0.4319605713159695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}